image

ISSN: 1935-1232 (P)

ISSN: 1941-2010 (E)

image
image

Citations Report

Clinical Schizophrenia & Related Psychoses : Citations & Metrics Report

Articles published in Clinical Schizophrenia & Related Psychoses have been cited by esteemed scholars and scientists all around the world. Clinical Schizophrenia & Related Psychoses has got h-index 41, which means every article in Clinical Schizophrenia & Related Psychoses has got 41 average citations.

Following are the list of articles that have cited the articles published in Clinical Schizophrenia & Related Psychoses.

  2022 2021 2020 2019 2018

Total published articles

105 141 28 8 28

Conference proceedings

0 0 0 0 0

Citations received as per Google Scholar, other indexing platforms and portals

543 553 590 563 587
Journal total citations count 6601
Journal impact factor 6.49
Journal 5 years impact factor 12.17
Journal cite score 11.19
Journal h-index 41
Journal h-index since 2019 26
Javitt, Daniel C. "Glutamate and schizophrenia: from theory to treatment implications." Psychiatric Times 31, no. 9 (2014): 49-49.
Challa, Feyissa, Daniel Seifu, Meron Seleshi, Tigist Getahun, Desta Kassa, Melkam Alemayehu, Miraf Mesfin, Yimtubezinash Woldeamanuel, Abebaw Fekadu, and Zeleke Geto. "Inflammatory Markers in Patients With Treatment-Resistant Schizophrenia in Ethiopia: A Comparative Study." (2021).
Levi, Linda, Jacob S. Ballon, and Joshua T. Kantrowitz. "Investigational treatments for cognitive impairment in schizophrenia: the authors examine the landscape of drug and nondrug therapies under active investigation for cognitive impairment in schizophrenia." Current Psychiatry 12, no. 9 (2013): 38-44.
Challa, Feyissa, Daniel Seifu, Meron Sileshi, Tigist Getahun, Zeleke Geto, Desta Kassa, Melkam Alemayehu, Miraf Mesfin, Abebaw Fekadu, and Yimtubezinash Woldeamanuel. "Serum level of high sensitive C-reactive protein and IL? 6 markers in patients with treatment-resistant schizophrenia in Ethiopia: a comparative study." BMC psychiatry 21, no. 1 (2021): 1-8.
Guimarães, Tiago M., Mara RC Guimarães, Ícaro AF Oliveira, Renata F. Leoni, Antonio C. Santos, Serdar M. Dursun, Jose AS Crippa et al. "Mononitrate Isosorbide as an Adjunctive Therapy in Schizophrenia: A Randomized Controlled Crossover Trial." Journal of Clinical Psychopharmacology 41, no. 3 (2021): 260-266.
de Bartolomeis, Andrea, Livia Avvisati, Felice Iasevoli, and Carmine Tomasetti. "Intracellular pathways of antipsychotic combined therapies: implication for psychiatric disorders treatment." European journal of pharmacology 718, no. 1-3 (2013): 502-523.
Davis, Michael C., and Stephen R. Marder. "Novel approaches for treating schizophrenia." Future Medicine Ltd, 2012.
Roberts, Rosalinda C., Joy K. Roche, Shahza M. Somerville, and Robert R. Conley. "Ultrastructural Distinctions Between Treatment Responders and Non-Responders in Schizophrenia: Postmortem Studies of the Striatum." Mental Illnesses-Evaluation, Treatments and Implications. InTech (2011): 261-286.
Aymen, Kachouchi, Zemrani Yassin, Ahroui Yassine, Salim Said, Berghalout Mohammed, Adali Imane, Manoudi Fatiha, Chabaa Laila, and Asri Fatima. "C-Reactive Protein and Aggression in Patients with Schizophrenia." International Journal of Psychological and Brain Sciences 4, no. 2 (2019): 7.
Strzelecki, Dominik, and Jolanta Rabe-Jab?o?ska. "Zmiana w zakresie objawów pozytywnych, negatywnych oraz psychopatologii ogólnej u pacjentów ze schizofreni? otrzymuj?cych augmentacj? leczenia przeciwpsychotycznego glicyn?: wyniki wst?pnego 10-tygodniowego badania otwartego." Psychiatria Polska 45, no. 6 (2011): 825-837.
Manu, Peter, Nilofar Sarvaiya, Liliana M. Rogozea, John M. Kane, and Christoph U. Correll. "Benign ethnic neutropenia and clozapine use: a systematic review of the evidence and treatment recommendations." The Journal of clinical psychiatry 77, no. 7 (2016): 0-0.
Nooijen, Patty MM, Felix Carvalho, and Robert J. Flanagan. "Haematological toxicity of clozapine and some other drugs used in psychiatry." Human Psychopharmacology: Clinical and Experimental 26, no. 2 (2011): 112-119.
Citrome, Leslie. "Treatment-resistant schizophrenia: what's next." Schizophrenia research 133, no. 1-3 (2011): 1-2.
Occhieppo, Victoria Belén, Osvaldo Martín Basmadjian, Natalia Andrea Marchese, Anahí Rodríguez, Andrea Jaime, Malena Herrera, and Claudia Bregonzio. "Glial Cells in the Schizophrenia Puzzle: Angiotensin II Role." In Psychiatry and Neuroscience Update, pp. 169-181. Springer, Cham, 2021.
Song, Cai, Yih-Shyuan Wu, Zhi-You Yang, Allan V. Kalueff, Yin-Yin Tsao, Yilong Dong, and Kuan-Pin Su. "Astrocyte-Conditioned Medium Protects Prefrontal Cortical Neurons from Glutamate-Induced Cell Death by Inhibiting TNF-? Expression." Neuroimmunomodulation 26, no. 1 (2019): 33-42.
Jackson, Chris, Eleanor Baggott, Mark Bernard, Ruth Clutterbuck, Diane Ryles, and Erin Turner. Recovering from a first episode of psychosis: An integrated approach to early intervention. Routledge, 2019.
Paribello, Pasquale, Mirko Manchia, Massimo Zedda, Federica Pinna, and Bernardo Carpiniello. "Leukocytosis Associated with Clozapine Treatment: A Case Series and Systematic Review of the Literature." Medicina 57, no. 8 (2021): 816.
Sapkota, Kiran, Kim Dore, Kang Tang, Mark Irvine, Guangyu Fang, Erica S. Burnell, Roberto Malinow, David E. Jane, and Daniel T. Monaghan. "The NMDA receptor intracellular C-terminal domains reciprocally interact with allosteric modulators." Biochemical pharmacology 159 (2019): 140-153.
I??k, Asl?han Özlem Polat, U?ur Çak?r, and Nermin Gündüz. "Leukocytosis after clozapine treatment in a patient with chronic schizophrenia." (2016).
Klein, Corinna, and Anton Bespalov. "Development of novel therapy of schizophrenia in children and adolescents." Expert opinion on investigational drugs 23, no. 11 (2014): 1531-1540.